ISX-9: A Step Forward in Growing Insulin-Producing Cells from Stem Cells
Researchers have identified a compound that improves the development of beta-like cells from stem cells—a key step toward potentially restoring the body's own insulin production in Type 1 diabetes.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- ISX-9 helps expand the specific pancreatic cells needed to create functioning beta cells from stem cells
- This advancement could improve the yield and function of lab-grown islets for transplantation
- The research reveals how signaling between cells and their surrounding matrix influences which cells become beta cells
- This work is part of ongoing efforts to develop cell replacement therapies for Type 1 diabetes
Why Growing Beta Cells Matters
Type 1 diabetes occurs when the body's insulin-producing beta cells are lost or destroyed. Scientists have long explored whether stem cell-derived islets—insulin-producing tissue grown in the lab—could restore the body's ability to make its own insulin. This approach differs from current insulin replacement therapy and could potentially transform how Type 1 diabetes is managed.
The challenge has been making enough functional beta cells efficiently. A new study published in Developmental Cell offers progress on this frontier.
What ISX-9 Does
Researchers led by Zhao and Liang found that a compound called ISX-9 improves the process of converting stem cells into beta cells. Specifically, ISX-9 expands PDX1+/NKX6-1+ pancreatic progenitors—intermediate cells that are specialized to become beta cells.
By improving this expansion, ISX-9 increases both the number of beta-like cells that can be generated and their function, meaning they work more like natural insulin-producing cells.
Understanding How Cells Know What to Become
Beyond ISX-9's direct effects, the research revealed something important about cell development: how cells interact with their surrounding environment—specifically the extracellular matrix—influences whether they become beta cells. This insight could guide future efforts to improve stem cell differentiation.
These findings add to our understanding of the signals and conditions needed to guide stem cells reliably toward becoming functional insulin-producing tissue.
What Comes Next
This work represents a step forward in the lab toward developing stem cell-derived islet transplants. However, significant research and development remain before this approach could reach patients. Future work will need to confirm these results, optimize the process further, and test safety and effectiveness in clinical settings.
For people with Type 1 diabetes and their families, this kind of research keeps alive the possibility of therapies that restore the body's natural insulin production—an active area of scientific development.
Evidence label
Source: Developmental cell. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Our own writing on the same ground.
- OriginalType 1 diabetes research watch: recent papers and DOI records worth sortingA daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
- OriginalType 1 diabetes research watch: recent papers and DOI records worth sortingA daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
- OriginalType 1 diabetes research watch: recent papers and DOI records worth sortingA daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryCure & AdvancementsGene-Edited Islets Show Promise, But Long-Term Questions RemainPubMed indexed literature
- Research summaryCure & AdvancementsHow Islet Size Shapes Cell Composition: What Scientists Found in Healthy PancreasesPubMed indexed literature
- Research summaryCure & AdvancementsStem Cell-Derived Islets: A New Research Path Toward Restoring Insulin ProductionPubMed indexed literature
- Research summaryCure & AdvancementsBerberine Shows Promise for Pancreatic Cell Recovery in Type 1 Diabetes ResearchPubMed indexed literature
- Research summaryCure & AdvancementsHow Gut Bacteria May Influence Type 1 Diabetes Risk Through Immune ControlPubMed indexed literature
- Research summaryCure & AdvancementsNew Blood Test May Help Identify Type 1 Diabetes EarlierPubMed indexed literature